FDA Seeks Comments on IOM Report

Julie Ritzer Ross | | Radiology Business | Business Intelligence
The U.S. Food and Drug Administration (FDA) is soliciting public comments regarding last week's report on its 510(k) process for regulating medical devices. Produced by the Institute of Medicine (IOM) and released last Friday, the report sharply criticizes the 510(k) process, deeming it inadequate for its purpose. It indicates that in particular, the process by which new 510(k) applications are compared to previously cleared devices is “flawed” and, as such, should be eschewed in favor of another approach. The IOM executed the report at the FDA’s behest. The effort represents part of a regulatory review process initiated by the agency in 2009. As a next step in this process, the FDA plans to accept public comment on the report through September 30, 2011. To comment on the report online, click here: http://www.regulations.gov. Written comments should be sent to: Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Room1061, Rockville, MD 20852. Comments should reference “FR Doc No: 2011-19353”. To read the report, click here: http://www.iom.edu/Activities/PublicHealth/510KProcess.aspx.

Julie Ritzer Ross,

Contributor

Related Content

Orano Med breaks ground on $265M thorium production site
Image-interpretation market scoreboard: Radiologists 72%, others 28%
Lantheus lands rights to budding radiopharmaceuticals for initial outlay of $35M
17 short-term strategies to address the national radiologist shortage
‘SR’ onboards another independent practice, its 1st in the Natural State
Analysis: Allied radiology professionals generate millions of dollars per year in indirect revenues alone

Around the web

Health Imaging
Nearly $800,000 settlement offered to family of man who died during MRI exam

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.